meitshel

SGMO - long -catalyst play

Largo
meitshel Actualizado   
NASDAQ:SGMO   Sangamo Therapeutics, Inc.
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

This is not a financial advice!

Upcoming catalyst on 31st. of March

Keep an eye on 0.65 , 1.10 and 1.70 levels- needs to get broken for a further upmove.

SL under 0.3

TP approx. 2.8

Most info on the chart.

Trade carefully!
Comentarios:
i would say good timing
Comentarios:
fucking nailed it again! feel free to take gains if u want.
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.